C18:1 Ceramide-d7
C18:1 Ceramide-d7 is the deuterated-labeled C18:1-Ceramide (HY-141578). C18:1-Ceramide is a ceramide subspecies belonging to bioactive lipids. C18:1-Ceramide exhibits activities of inducing skeletal muscle insulin resistance and affecting metabolism. C18:1-Ceramide can be used in the research of obesity, type 2 diabetes (T2D), insulin resistance and other related metabolic diseases.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 1942907-50-7
- Formel: C36H62D7NO3
- Molecular Weight:570.98
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Endogenous Metabolite Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
Anwendung
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
CAS. Nr. 1942907-50-7
-
Unlabeled CAS 5966-28-9
-
Molecular Weight 570.98
-
Formel C36H62D7NO3
-
SMILES
CCCCCCCC/C=C\CCCCCCCC(N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Keywords
- C18:1 Ceramide-d7
- 1942907-50-7
- Isotope-Labeled Compounds
- Endogenous Metabolite
- mouse blood mononuclear cells
- murine immune cells
- human L02 hepatocytes
- alkaline ceramidase 3
- colonic epithelial cells
- primary peritoneal macrophages
- Acer3-deficient mouse primary hepatocytes
- DSS-induced colitis
- skeletal muscle insulin resistance
- colon tissues
- Inhibitor
- inhibitor
- inhibit